当前位置：
X-MOL 学术
›
Signal Transduct. Target Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models.
Signal Transduction and Targeted Therapy ( IF 39.3 ) Pub Date : 2021-09-03 , DOI: 10.1038/s41392-021-00666-5 Jiansheng Fan 1 , Xinlei Zhuang 1 , Xiaoyue Yang 1 , Yingchun Xu 1 , Zhan Zhou 1 , Liqiang Pan 1 , Shuqing Chen 1
中文翻译：
一种多价双互补位 EGFR 靶向纳米抗体药物偶联物在实体瘤模型中显示出有效的抗癌活性。
更新日期：2021-09-03
Signal Transduction and Targeted Therapy ( IF 39.3 ) Pub Date : 2021-09-03 , DOI: 10.1038/s41392-021-00666-5 Jiansheng Fan 1 , Xinlei Zhuang 1 , Xiaoyue Yang 1 , Yingchun Xu 1 , Zhan Zhou 1 , Liqiang Pan 1 , Shuqing Chen 1
Affiliation
中文翻译：
一种多价双互补位 EGFR 靶向纳米抗体药物偶联物在实体瘤模型中显示出有效的抗癌活性。
京公网安备 11010802027423号